Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Sigal, Radius, SHIN-NY, & More 02/28/14 Boston
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
Flexion Prices IPO at $13, Heads to Nasdaq Tomorrow 02/11/14 Boston
Ampio Pharmaceuticals Starts Final Study for Osteoarthritis Treatment 01/15/14 Boulder/Denver
East Coast Biotech Roundup: Gerngross, Akili, Intercept, & More 01/10/14 Boston
Flexion Files for IPO, Seeks $86M to Develop Osteoarthritis Drugs 01/08/14 Boston
Flexion’s Long-Lasting Steroid Injection Hits Mark in Phase 2 Trial 06/26/13 Boston
East Coast Life Sciences Roundup: Zafgen, Moderna, Merck, More 12/07/12 Boston
Flexion Therapeutics Secures $20 Million to Fight Osteoarthritis 12/04/12 Boston
Flexion Overhaul Bears Fruit With Upbeat Data From Arthritis Trial 05/30/12 Boston
ConforMIS Shapes Corporate Expansion with $50M D Round 07/13/09 Boston
Former CEO Alexis Borisy Voices Mixed Feelings on CombinatoRx Saga 07/06/09 Boston
Genzyme Nabs Two Key Regulatory Approvals, Expected to Trigger Revenue Growth 02/26/09 Boston
FDA Panel Gives Nod to Genzyme Osteoarthritis Treatment 12/09/08 Boston
Genzyme Expects FDA Review of Myozyme Factory by Thanksgiving Weekend 09/23/08 Boston
Page 1 of 1